{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae Synergies plus\u2122 Gram-Positive MIC/Combo Panels",
        "MicroScan\u00ae Synergies plus\u2122 Gram-Positive MIC/Combo Panels with clindamycin"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K070860",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LRG",
        "JWY",
        "LTT"
    ],
    "Summary Letter Date": "March 27, 2007",
    "Summary Letter Received Date": "March 28, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clindamycin"
    ],
    "Specimen Type(s)": [
        "Colonies of rapidly growing aerobic and facultative anaerobic gram-positive enterococci and staphylococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "WalkAway\u00ae SI System",
        "MicroScan\u00ae Instrumentation"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution antimicrobial susceptibility testing",
        "Dehydrated miniaturized panels"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Synergies plus Gram-Positive MIC/Combo Panels for antimicrobial susceptibility testing with addition of clindamycin.",
    "Indications for Use Summary": "Used to determine quantitative and/or qualitative antimicrobial agent susceptibility of colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-positive enterococci and staphylococci, including clindamycin susceptibility testing for Staphylococcus spp.",
    "fda_folder": "Microbiology"
}